Full Text View
Tabular View
No Study Results Posted
Related Studies
Capecitabine in Women With Operable Breast Cancer
This study is ongoing, but not recruiting participants.
Study NCT00148720   Information provided by Dana-Farber Cancer Institute
First Received: September 7, 2005   Last Updated: August 24, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Invasive Breast Carcinoma
Primary Invasive Breast Cancer
Stage I Breast Cancer
Stage II Breast Cancer
Stage III Breast Cancer
Additional conditions recognized in this trial
Breast Neoplasms
Carcinoma
More general conditions related to this trial
Breast Diseases
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Skin Diseases
Interventions listed in this trial
Capecitabine
More general drug interventions related to this trial
Antimetabolites
Antimetabolites, Antineoplastic
Antineoplastic Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Dana-Farber Cancer Institute
Hoffmann-La Roche
Beth Israel Deaconess Medical Center
Brigham and Women's Hospital
Faulkner Hospital


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services